Citrulline a more suitable substrate than arginine to restore no production and the microcirculation during endotoxemia

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Wijnands, Karolina A P ^a,b   Vink, Hans ^a,c   Briedé, Jacob J ^a,b   van Faassen, Ernst E ^d   Lamers, Wouter H ^a,b   Buurman, Wim A ^a,b   Poeze, Martijn ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; CITRULLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PLACEBO; SODIUM CHLORIDE; INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INFUSION; DRUG TISSUE LEVEL; ELECTRON SPIN RESONANCE; ENDOTOXEMIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE BLOOD FLOW; INTESTINE VILLUS; JEJUNUM; MALE; MICROCIRCULATION; MOUSE; NONHUMAN; WESTERN BLOTTING; ANIMAL; BIOAVAILABILITY; BIOSYNTHESIS; C57BL MOUSE; COMPARATIVE STUDY; DIET SUPPLEMENTATION; GENE EXPRESSION REGULATION; INTRACELLULAR SPACE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

MUS;

ANIMALS; ARGININE; BIOLOGICAL AVAILABILITY; CITRULLINE; DIETARY SUPPLEMENTS; ENDOTOXEMIA; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INTRACELLULAR SPACE; MALE; MICE; MICE, INBRED C57BL; MICROCIRCULATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III;

EID: 84861536370     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037439     Document Type: Article

References (58)

1. Ince C, (2002) The microcirculation unveiled. Am J Respir Crit Care Med 166: 1-2.
2. Boerma EC, Mathura KR, van der Voort PH, Spronk PE, Ince C, (2005) Quantifying bedside-derived imaging of microcirculatory abnormalities in septic patients: a prospective validation study. Crit Care 9: R601-606.
3. Crouser ED, Julian MW, Dorinsky PM, (1999) Ileal VO(2)-O(2) alterations induced by endotoxin correlate with severity of mitochondrial injury. Am J Respir Crit Care Med 160: 1347-1353.
4. Kaul DK, Zhang X, Dasgupta T, Fabry ME, (2008) Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress. Am J Physiol Heart Circ Physiol 295: H39-47.
5. Krejci V, Hiltebrand LB, Erni D, Sigurdsson GH, (2003) Endothelin receptor antagonist bosentan improves microcirculatory blood flow in splanchnic organs in septic shock. Crit Care Med 31: 203-210.
6. Ince C, Sinaasappel M, (1999) Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med 27: 1369-1377.
7. Lehr HA, Bittinger F, Kirkpatrick CJ, (2000) Microcirculatory dysfunction in sepsis: a pathogenetic basis for therapy? J Pathol 190: 373-386.
8. McCuskey RS, (1999) Hepatic and splanchnic microvascular responses to inflammation and shock. Hepatogastroenterology 46 (Suppl 2): 1464-1467.
9. Stechmiller JK, Treloar D, Allen N, (1997) Gut dysfunction in critically ill patients: a review of the literature. Am J Crit Care 6: 204-209.
10. Bruins MJ, Luiking YC, Soeters PB, Akkermans LM, Deutz NE, (2003) Effect of prolonged hyperdynamic endotoxemia on jejunal motility in fasted and enterally fed pigs. Ann Surg 237: 44-51.
11. Schmidt H, Secchi A, Wellmann R, Bach A, Bohrer H, et al. (1996) Effect of endotoxemia on intestinal villus microcirculation in rats. J Surg Res 61: 521-526.
12. Pittner A, Nalos M, Asfar P, Yang Y, Ince C, et al. (2003) Mechanisms of inducible nitric oxide synthase (iNOS) inhibition-related improvement of gut mucosal acidosis during hyperdynamic porcine endotoxemia. Intensive Care Med 29: 312-316.
13. Derikx JP, Poeze M, van Bijnen AA, Buurman WA, Heineman E, (2007) Evidence for intestinal and liver epithelial cell injury in the early phase of sepsis. Shock 28: 544-548.
14. Matheson PJ, Wilson MA, Garrison RN, (2000) Regulation of intestinal blood flow. J Surg Res 93: 182-196.
15. Luiking YC, Engelen MP, Deutz NE, (2010) Regulation of nitric oxide production in health and disease. Curr Opin Clin Nutr Metab Care 13: 97-104.
16. Flam BR, Eichler DC, Solomonson LP, (2007) Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle. Nitric Oxide 17: 115-121.
17. Luiking YC, Poeze M, Ramsay G, Deutz NE, (2009) Reduced citrulline production in sepsis is related to diminished de novo arginine and nitric oxide production. Am J Clin Nutr 89: 142-152.
18. Kubes P, McCafferty DM, (2000) Nitric oxide and intestinal inflammation. Am J Med 109: 150-158.
19. Luiking YC, Poeze M, Dejong CH, Ramsay G, Deutz NE, (2004) Sepsis: an arginine deficiency state? Crit Care Med 32: 2135-2145.
20. Jeyabalan G, Klune JR, Nakao A, Martik N, Wu G, et al. (2008) Arginase blockade protects against hepatic damage in warm ischemia-reperfusion. Nitric Oxide 19: 29-35.
21. Durante W, Johnson FK, Johnson RA, (2007) Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 34: 906-911.
22. Luiking YC, Hallemeesch MM, de Jonge WJ, Lamers WH, Deutz NE, (2008) Reduced citrulline availability by OTC-deficiency in mice is related to reduced nitric oxide production. Am J Physiol Endocrinol Metab 295: E1315-1322.
23. Hollenberg SM, Broussard M, Osman J, Parrillo JE, (2000) Increased microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide synthase. Circ Res 86: 774-778.
24. Nathan C, Xie QW, (1994) Nitric oxide synthases: roles, tolls, and controls. Cell 78: 915-918.
25. Chen K, Inoue M, Wasa M, Fukuzawa M, Kamata S, et al. (1997) Expression of endothelial constitutive nitric oxide synthase mRNA in gastrointestinal mucosa and its downregulation by endotoxin. Life Sci 61: 1323-1329.
26. Vissers YL, Debats IB, Luiking YC, Jalan R, van der Hulst RR, et al. (2004) Pros and cons of L-arginine supplementation in disease. Nutr Res Rev 17: 193-210.
27. Shen LJ, Beloussow K, Shen WC, (2005) Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway. Biochem Pharmacol 69: 97-104.
28. Bode-Boger SM, Boger RH, Galland A, Tsikas D, Frolich JC, (1998) L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship. Br J Clin Pharmacol 46: 489-497.
29. Boger RH, Bode-Boger SM, (2001) The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol 41: 79-99.
30. Fukatsu K, Ueno C, Maeshima Y, Hara E, Nagayoshi H, et al. (2004) Effects of L-arginine infusion during ischemia on gut blood perfusion, oxygen tension, and circulating myeloid cell activation in a murine gut ischemia/reperfusion model. JPEN J Parenter Enteral Nutr 28: 224-230; discussion 230-221.
31. Braulio VB, Ten Have GA, Vissers YL, Deutz NE, (2004) Time course of nitric oxide production after endotoxin challenge in mice. Am J Physiol Endocrinol Metab 287: E912-918.
32. Hallemeesch MM, Cobben DC, Dejong CH, Soeters PB, Deutz NE, (2000) Renal amino acid metabolism during endotoxemia in the rat. J Surg Res 92: 193-200.
33. Olfert ED, Godson DL, (2000) Humane endpoints for infectious disease animal models. Ilar J 41: 99-104.
34. Poeze M, Bruins MJ, Kessels F, Luiking YC, Lamers WH, et al. (2011) Effects of L-arginine pretreatment on nitric oxide metabolism and hepatosplanchnic perfusion during porcine endotoxemia. Am J Clin Nutr 93: 1237-1247.
35. Osowska S, Duchemann T, Walrand S, Paillard A, Boirie Y, et al. (2006) Citrulline modulates muscle protein metabolism in old malnourished rats. Am J Physiol Endocrinol Metab 291: E582-586.
36. Elwafi F, Curis E, Zerrouk N, Neveux N, Chaumeil JC, et al. (2011) Endotoxemia affects citrulline, arginine and glutamine bioavailability. Eur J Clin Invest 42: 282-289.
37. Groner W, Winkelman JW, Harris AG, Ince C, Bouma GJ, et al. (1999) Orthogonal polarization spectral imaging: a new method for study of the microcirculation. Nat Med 5: 1209-1212.
38. Spronk PE, Ince C, Gardien MJ, Mathura KR, Oudemans-van Straaten HM, et al. (2002) Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 360: 1395-1396.
39. Massberg S, Eisenmenger S, Enders G, Krombach F, Messmer K, (1998) Quantitative analysis of small intestinal microcirculation in the mouse. Res Exp Med 198: 23-35.
40. De Backer D, Hollenberg S, Boerma C, Goedhart P, Buchele G, et al. (2007) How to evaluate the microcirculation: report of a round table conference. Crit Care 11: R101.
41. Verdant CL, De Backer D, Bruhn A, Clausi CM, Su F, et al. (2009) Evaluation of sublingual and gut mucosal microcirculation in sepsis: a quantitative analysis. Crit Care Med 37: 2875-2881.
42. van Eijk HM, Rooyakkers DR, Deutz NE, (1993) Rapid routine determination of amino acids in plasma by high-performance liquid chromatography with a 2-3 microns Spherisorb ODS II column. J Chromatogr 620: 143-148.
43. van Faassen EE, Koeners MP, Joles JA, Vanin AF, (2008) Detection of basal NO production in rat tissues using iron-dithiocarbamate complexes. Nitric Oxide 18: 279-286.
44. Poeze M, Bruins MJ, Luiking YC, Deutz NE, (2010) Reduced caloric intake during endotoxemia reduces arginine availability and metabolism. Am J Clin Nutr 91: 992-1001.
45. Luiking YC, Hallemeesch MM, Vissers YL, Lamers WH, Deutz NE, (2004) In vivo whole body and organ arginine metabolism during endotoxemia (sepsis) is dependent on mouse strain and gender. J Nutr 134: 2768S-2774S; discussion 2796S-2797S.
46. Luiking YC, Hallemeesch MM, Lamers WH, Deutz NE, (2005) The role of NOS2 and NOS3 in renal protein and arginine metabolism during early endotoxemia in mice. Am J Physiol Renal Physiol 288: F816-822.
47. Hallemeesch MM, Lamers WH, Deutz NE, (2002) Reduced arginine availability and nitric oxide production. Clin Nutr 21: 273-279.
48. Ventura G, Moinard C, Segaud F, Le Plenier S, Cynober L, et al. (2010) Adaptative response of nitrogen metabolism in early endotoxemia: role of ornithine aminotransferase. Amino Acids 39: 1417-1426.
49. Bruins MJ, Soeters PB, Lamers WH, Meijer AJ, Deutz NE, (2002) L-arginine supplementation in hyperdynamic endotoxemic pigs: effect on nitric oxide synthesis by the different organs. Crit Care Med 30: 508-517.
50. Goodwin BL, Solomonson LP, Eichler DC, (2004) Argininosuccinate synthase expression is required to maintain nitric oxide production and cell viability in aortic endothelial cells. J Biol Chem 279: 18353-18360.
51. Hartman WJ, Torre PM, Prior RL, (1994) Dietary citrulline but not ornithine counteracts dietary arginine deficiency in rats by increasing splanchnic release of citrulline. J Nutr 124: 1950-1960.
52. Waugh WH, Daeschner CW, 3rd, Files BA, McConnell ME, Strandjord SE, (2001) Oral citrulline as arginine precursor may be beneficial in sickle cell disease: early phase two results. J Natl Med Assoc 93: 363-371.
53. Barr FE, Tirona RG, Taylor MB, Rice G, Arnold J, et al. (2007) Pharmacokinetics and safety of intravenously administered citrulline in children undergoing congenital heart surgery: potential therapy for postoperative pulmonary hypertension. J Thorac Cardiovasc Surg 134: 319-326.
54. Smith HA, Canter JA, Christian KG, Drinkwater DC, Scholl FG, et al. (2006) Nitric oxide precursors and congenital heart surgery: a randomized controlled trial of oral citrulline. J Thorac Cardiovasc Surg 132: 58-65.
55. Orea-Tejeda A, Orozco-Gutierrez JJ, Castillo-Martinez L, Keirns-Davies C, Montano-Hernandez P, et al. (2010) The effect of L-arginine and citrulline on endothelial function in patients in heart failure with preserved ejection fraction. Cardiol J 17: 464-470.
56. Orozco-Gutierrez JJ, Castillo-Martinez L, Orea-Tejeda A, Vazquez-Diaz O, Valdespino-Trejo A, et al. (2010) Effect of L-arginine or L-citrulline oral supplementation on blood pressure and right ventricular function in heart failure patients with preserved ejection fraction. Cardiol J 17: 612-618.
57. Tain YL, Hsieh CS, Lin IC, Chen CC, Sheen JM, et al. (2010) Effects of maternal L-citrulline supplementation on renal function and blood pressure in offspring exposed to maternal caloric restriction: the impact of nitric oxide pathway. Nitric Oxide 23: 34-41.
58. Koeners MP, van Faassen EE, Wesseling S, de Sain-van der Velden M, Koomans HA, et al. (2007) Maternal supplementation with citrulline increases renal nitric oxide in young spontaneously hypertensive rats and has long-term antihypertensive effects. Hypertension 50: 1077-1084.